Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Advancing Gene Silencing Research in Silkworms with dsRNA Delivery Through Feeding Chitosan Nanoparticles
Published on: October 4, 2024
Purification and characterization of two cysteine proteinase inhibitors from silkworm, Bombyx mori
Huan Yang1, Jianwei Li1, Qing Liu1
1State Key Laboratory of Silkworm Genome Biology, College of Biotechnology, Southwest University, Chongqing, Beibei, Chongqing 400715, China.
Abstract:
Cysteine proteinase inhibitors from silkworm are selective inhibitors with low molecular weight and regulate cathepsin L-like cysteine proteinase activity, thus, affecting silkworm metamorphosis. In a previous study, two cysteine proteinase inhibitors, BCPI and BmCPI, were identified in the silkworm genome. To characterize these inhibitors, we expressed and purified them in an Escherichia coli system and analyzed their structure and inhibitory activity in vitro. Both inhibitors showed strong tolerance to high temperature. Their CD spectra revealed that their secondary structures could be recovered by a gradual decrease in temperature. Compared to BCPI, BmCPI exhibited weak inhibitory activity toward cathepsin L. BCPI activity was significantly decreased when its C-terminus was truncated, whereas BmCPI activity increased considerably when the C-terminus tail of BCPI was attached to BmCPI. Additionally, the inhibitory activity of BCPI was strongly reduced if R31 was mutated to A31. In summary, two cysteine proteinase inhibitors from silkworm were characterized in the present study, which facilitates an understanding of the interaction mechanism between cysteine proteinase and its inhibitors in the silkworm.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Dipeptidyl Peptidase 4 Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...

